The Role of von Willebrand Factor in Platelet Function

Philip G. de Groot

doi:10.1055/s-2002-27815

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2002; 28(2): 133-138
DOI: 10.1055/s-2002-27815

The Role of von Willebrand Factor in Platelet Function

Philip G. de Groot

University Medical Center, Utrecht, The Netherlands

Abstract

ABSTRACT

von Willebrand factor (vWF) has essential functions in the very first stage of hemostasis. At the site of vascular damage vWF binds immediately to exposed collagens, thereby facilitating the adhesion of platelets. After a first layer of platelets has been formed, vWF is also crucial as a link between platelets in the forming thrombus. In this article, the current knowledge on the role of vWF in primary hemostasis is reviewed.

KEYWORDS

von Willebrand factor - platelets - platelet adhesion - glycoprotein receptors - von Willebrand disease

Volltext

Referenzen

REFERENCES

1 Jaffe E A, Hoyer L W, Nachman R L. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA . 1974; 71 1906-1909
2 Nachman R, Levine R, Jaffe E A. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest . 1977; 60 914-921
3 Sadler J E. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem . 1998; 67 395-424
4 Ruggeri Z M. Structure and function of von Willebrand factor. Thromb Haemost . 1999; 82 576-584
5 Rohdeghiero F, Castaman G, Ruggeri Z M, Tosetto A. The bleeding time in normal subjects is mainly determined by platelet von Willebrand factor and is independent from blood group. Thromb Res . 1992; 65 605-615
6 Sarode R, Goldstein J, Sussman I I, Nagel R L, Tsai H M. Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor. Br J Haematol . 2000; 109 857-864
7 Ewenstein B M. Von Willebrand's disease. Annu Rev Med . 1997; 48 525-545
8 Verweij C L, Diergaarde P J, Hart M, Pannekoek H. Full-length von Willebrand factor cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. EMBO J . 1986; 5 1839-1847
9 Siedlecki C A, Lestini B J, Kottke-Marchant K. Shear dependent changes in the three dimensional structure of von Willebrand factor. Blood . 1996; 88 2939-2950
10 Sakariassen K S, Bolhuis P A, Sixma J J. Human blood platelets adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature . 1979; 279 636-638
11 Celikel R, Ruggeri Z M, Varughese K I. Von Willebrand conformation and adhesive function is modulated by an internalized water molecule. Nature . 2000; 7 881-884
12 Read M S, Potter J Y, Brinkhous K M. Venom coagglutinin for detection of von Willebrand factor activity in animal plasmas. J Lab Clin Med . 1983; 101 74-82
13 Ruggeri Z M, Zimmerman T S. von Willebrand factor and von Willebrand disease. Blood . 1987; 70 895-904
14 Sadler J E, Matsushita T, Dong Z, Tuley E A, Westfield L A. Molecular mechanism and classification of von Willebrand disease. Thromb Haemost . 1995; 74 161-166
15 Lankhof H, van Hoeij M, Schiphorst M E. A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost . 1996; 75 950-958
16 Clemetson K J, Clemetson J M. Platelet GPIb-V-IX complex. Structure, function, physiology and pathology. Semin Thromb Hemost . 1995; 21 130-136
17 Savage B, Saldivar E, Ruggeri Z M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell . 1996; 84 289-297
18 Miura S, Li C Q, Cao Z. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ib alpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion. J Biol Chem . 2000; 275 7539-7546
19 Nieuwenhuis H K, Sakariassen K S, Houdijk W PM, Nievelstein P E M F, Sixma J J. Deficiency of platelet membrane glycoprotein Ia is associated with a decreased platelet adhesion to subendothelium. A defect in platelet spreading. Blood . 1986; 68 692-695
20 Arai M, Yamamoto N, Moroi M. Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency. Br J Haematol . 1995; 89 124-130
21 Kehrel B, Clementson K J, Anders O. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quarternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa and von Willebrand factor do not. Blood . 1998; 91 491-496
22 Beumer S, IJsseldijk M JW, de Groot G Ph, Sixma J J. Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GPIIb/IIIa and VLA5, and inhibition by heparin. Blood . 1994; 84 3724-3733
23 Weiss H J, Turitto V T, Baumgartner H R. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood . 1986; 67 322-330
24 Weiss H J, Turitto V T, Baumgartner H R. Further evidence that glycoprotein IIb-IIIa mediates platelet spreading on subendothelium. Thromb Haemost . 1991; 65 202-205
25 Wu Y P, de Groot G Ph, Sixma J J. Shear stress-induced detachment of blood platelets adhered to various adhesive surfaces under flow. Arterioscler Thromb Vasc Biol . 1997; 17 3202-3207
26 Kulkarni S, Dopheide S M, Yap C L. A revised model of platelet aggregation. J Clin Invest . 2000; 105 783-791
27 Ruggeri Z M. Old concepts and new developments in the study of platelet aggregation. J Clin Invest . 2000; 105 699-701
28 Ruggeri Z M, Dent J A, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood . 1999; 94 172-178
29 Wu Y P, Vink T, Schiphorst M. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-GPIb interaction and inhibited by vWF-GPIIb:IIIa interaction. Arterioscler Thromb Vasc Biol . 2000; 20 1661-1667
30 Tsuji S, Sugimoto M, Miyata S. Real time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood . 1999; 94 968-975
31 Weiss H J, Hawiger J, Ruggeri Z M. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest . 1989; 83 288-297
32 Berliner S, Niija K, Roberts J R, Houghten R A, Ruggeri Z M. Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interaction with other adhesive molecules. J Biol Chem . 1988; 263 7500-7505
33 Matsushita T, Meyer D, Sadler J E. Localization of von Willebrand factor-binding sites for platelet glycoprotein Ib and botrocetin by charged-to-alanine scanning mutagenesis. J Biol Chem . 2000; 275 11044-11049
34 Emsley J, Cruz M, Handin R, Liddington R. Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib. J Biol Chem . 1998; 273 10396-10401
35 Huizinga E G, Martijn van der Plas R, Kroon J, Sixma J J, Gros P. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding. Structure . 1997; 5 1147-1156
36 Bienkowska J, Cruz M, Atiemo A, Handin R, Liddington R. The von Willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motif. J Biol Chem . 1997; 272 25162-25167
37 Romein R AP, Bouma B, Wuyster W. Identification of the collagen binding site of the von Willebrand A3-domain. J Biol Chem . 2001; 276 9985-9991
38 Sadler J E, Mannucci P M, Berntorp E. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost . 2000; 84 160-174
39 Stel H V, Sakariassen K S, de Groot G Ph, van Mourik A J, Sixma J J. The von Willebrand factor in the vessel wall mediates platelet adherence. Blood . 1985; 65 85-90
40 Fressinaud E, Baruch D, Rothschild C, Baumgartner H R, Meyer D. Platelet von Willebrand factor: evidence for its involvement in platelet adhesion to collagen. Blood . 1987; 70 1214-1217
41 d'Allesio P, Zwaginga J J, de Boer C H. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor. Thromb Haemost . 1990; 64 227-231
42 de Groot G Ph, Federici A B, de Boer H C, et al. Von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally, but has an increased affinity for platelets. Proc Natl Acad Sci USA . 1989; 86 3793-3797
43 Nichols W C, Ginsburg D. von Willebrand disease. Medicine . 1997; 76 1-20
44 Hillery C A, Mancuso D J, Sadler E J, et al. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets. Blood . 1998; 91 1572-1581
45 Weiss H J, Meyer D, Rabinowitz R, et al. Pseudo-von Willebrand's disease. <~>An intrinsic platelet defect with aggregation by unmodified human factor VIII/Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med . 1982; 306 326-333
46 Russell S D, Roth G J. Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor. Blood . 1993; 81 1787-1791
47 Veyradier A, Jenkins S P, Fressinaud E, Meyer D. Acquired von Willebrand syndrome: from pathophysiology to management. Thromb Haemost . 2000; 84 175-182
48 van Genderen J P, Vink T, Michiels J J. Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen. Blood . 1994; 84 3378-3384